Fatal Donor‐Derived Kaposi Sarcoma Diagnosed at Autopsy and Allograft Explant in Two Recipients From a Single Donor: The Case for Risk‐Based HHV‐8 Screening

G.H. is a recipient of research grants from the Cystic Fibrosis Foundation, AstraZeneca, Regeneron, the University of Pittsburgh, and the NIH. G.H. also serves on the scientific advisory board of Sanofi and has served on the scientific advisory boards of Karius, AstraZeneca, and Pfizer. The other authors have no conflicts of interest to report. The authors have nothing to report.